Events


Adam Podmore on the commercialisation of Objective Acuity

Date: Friday, 28th July, 2017
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: Fale Pasifika
RSVP:
by replying with YES in the subject line to m.burgess@auckland.ac.nz

I am delighted to invite you on behalf of the IIB and NZBio, to the latest in our series of networking events to be held on Friday July 28th 4.30 for 5.00 pm start at our new venue: the University FALE PASIFIKA. This event is made possible with sponsorship from ATEED.

This month we welcome guest speaker Adam Podmore, CEO Objective Acuity speaking on the University of Auckland spin out company Objective Acuity.

Adam Podmore has 14 years’ experience in commercialisation of medical and health technologies. He has previously worked at Auckland UniServices and Investment New Zealand. In these roles, Adam led business planning, capital raises and executed several licensing deals.

Objective Acuity is a breakthrough company developing the next gold standard in vision screening and testing that can be used to test everyone, including young children.

There are many approaches to the measurement of vision but all rely on a cooperative subject and are intrinsically subjective. Through novel eye tracking approaches, Objective Acuity is developing the first automated and objective visual acuity screen and test.

In his talk Adam will discuss the technology, support from UniServices and the near term objectives of the company.

An invitation to a University of Auckland Bioscience Enterprise Forum, sponsored by ATEED

Date: Friday, 3rd March, 2017
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: Fale Pasifika

You are welcome to join us for the first Forum this year on March 3rd at 4.30 with sponsorship from ATEED in a new University Venue: the FALE PASIFIKA.

Guest Speaker: This month we welcome Hartley Atkinson, founder and CEO of AFT Pharmaceuticals speaking on the AFT story and the commercialisation of Maxigesic. We will also be presenting the Baldwin’s prize to the top student for the IP law paper.

New venue below. Please RSVP by responding “Yes” in the subject line.

Hartley Atkinson founded AFT in 1997 since when the company has grown rapidly to revenues $64m post listing on the NZX in 2015. Its best known product is Maxigesic now licensed in 111 countries with further agreements expected. Research and development has always been a key driver with AFT being the first NZ company to register a patented drug in Europe. It has conducted many clinical studies published in high impact journals. New developments include a novel patented drug delivery device and one key orphan drug development.

RSVP
Please reply YES in the subject line by email

Date and time
4.30-6.30 pm drinks and canapés (for 5.00 pm presentation), March 3rd

Venue
Fale Pasifika is on the University Campus on the northern side of the Business School’s Owen Glenn Building (best parking option) at 20 Wynyard Street, Grafton. Just exit the Owen Glenn Building, head past the Fisher and Paykel Auditorium and find the Fale on your right.

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd. This is close to the Fale Pasifika.

An invitation to a University of Auckland Bioscience Enterprise Forum, sponsored by ATEED

Date: Tuesday, 6th December, 2016
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: Fale Pasifika
Guest Speaker:  

You are welcome to join us at 4.30 pm on Tuesday December 6th at the Fale Pasifika for the public launch of the UniServices Inventors’ Fund featuring:

Andy Shenk, CEO UniServices, who will describe the purpose and scope of the Fund. Andy joined Auckland UniServices as CEO in 2013. For the first ten years of his career he was an academic at the University of Delaware, Yale University and U.C. Irvine before joining New Zealand company Genesis Research and Development Corporation Ltd. After seven years in research and senior management positions at Genesis, Andy moved to Fonterra where he held a variety of senior positions in research strategy, venture investment and most recently as Chief Scientist.
His talk will be supplemented by two presentations by winners from the University 2017 Velocity Programme which could be supported by the new Fund:
Jennifer Barnes on Spot Check a point of care diagnostic for infectious disease.
Neil Birrell on Hexacycle, technology for the conversion of food waste to stock or fish food.

This event is sponsored by ATEED. Venue below.

RSVP
Please reply YES in the subject line by email.

Date and time
4.30-6.30 pm drinks and canapés (for 5.00 pm presentation), Tuesday December 6th

Venue
Fale Pasifika is on the University Campus on the northern side of the Business School’s Owen Glenn Building (best parking option) at 20 Wynyard Street, Grafton. Just exit the Owen Glenn Building, head past the Fisher and Paykel Auditorium and find the Fale on your right.

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd. This is close to the Fale Pasifika.

An invitation to a University of Auckland Bioscience Enterprise Forum, sponsored by ATEED

Date: Wednesday, 9th November, 2016
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: Fale Pasifika
Guest Speaker:  This month we welcome Duncan Mackintosh speaking on two biopolymer start-ups, Aduro Biopolymers and Ligar; From Lab to Market

Both these companies are strongly connected with the primary sector:

• Aduro make Novatein, a biodegradable biopolymer from the red meat industry designed for eco-friendly applications at reasonable prices.

• Ligar offer a platform technology but an example application is the highly selective filtration of wine to remove smoke taint or crop chemicals.

Duncan Mackintosh has been the New Zealand Investment Manager for Brandon Capital Partners since May 2016.

Before this Duncan was the Chief Executive of WaikatoLink Ltd the commercialisation company of the University of Waikato, Hamilton, New Zealand. In addition to commercialisation experience, Duncan has led a range of initiatives including the development of seed funds, an international internship programme, and collaborations, including KiwiNet - a consortium of 15 New Zealand research organisations to facilitate commercialisation. Duncan has a particular interest in the agritech and life science sectors, is founder of a number of start-up ventures and has held Directorships with Aduro Biopolymers, Ligar Polymers, Aldera Animal Health, PA Therapeutics and Auramer Bio. Prior to joining WaikatoLink, he held roles in commercialisation and technology incubator development and management.

Duncan has a BVSc from Massey University and spent 5 years in clinical practice, including leadership roles during the 2001 foot and mouth outbreak in the UK.

New venue below. Please RSVP by responding “Yes” in the subject line

RSVP
Please reply YES in the subject line by email

Date and time
4.30-6.30 pm drinks and canapés (for 5.00 pm presentation), Wednesday 9th November

Venue
Fale Pasifika which is on the University Campus on the northern side of the Business School’s Owen Glenn Building (best parking option) at 20 Wynyard Street, Grafton. Just exit the Owen Glenn Building, head past the Fisher and Paykel Auditorium and find the Fale on your right.

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd. This is close to the Fale Pasifika.

An invitation to a University of Auckland Bioscience Enterprise Forum, sponsored by ATEED

Date: Wednesday, 14th September, 2016
Time:
9:00am - 5:00pm.
Venue:
Aotea Centre, Auckland
2016 New Zealand Bioactives Symposium

Our September Forum will be combined with the NZBio Bioactives Symposium where we will be sponsoring the networking event at the end of the day. To register for this event please click here.

Proudly brought to you by NZBIO, ATEED (Auckland Tourism, Events and Economic Development) and Natural Products New Zealand, the NZ Bioactives Symposium is being hosted at the Aotea Centre in Auckland on 14 September. New Zealand’s competitive advantage across the value chain has enabled a vibrant bioactives sector with solid underlying fundamentals that provide a strong platform for future growth. The symposium features a number of high profile speakers exploring the opportunities and challenges of creating value from New Zealand’s unique flora and fauna. The strong symposium style educational program will appeal to anyone with an interest in bioactive compounds derived from our diverse and exciting natural world.

Registration for the full day symposium is $230 (plus GST). Save 50% if you are also attending the NZBIO Conference 2016: registration cost: $115 (plus GST). When you register, please tick the box for 'Attending NZBIO Conference'

Click here to register for the NZBIO 2016 Conference


An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 12th August, 2016
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences.
Guest Speaker:  This month we welcome Brendan O'Connell speaking on the topic:
Beyond the line of Sight. Farming and the Future of Food

In November Tru-Test (and the their partners Callaghan Innovation and NZTE) presented a remarkably thought provoking event with this title in Auckland featuring a line-up of highly-regarded entrepreneurial scientists, futurists and international academics. It was attended by around 400 industry leaders.

It concluded we stand at a unique moment in history. Emerging technologies and market conditions are converging to affect the demand, production and distribution of food over the next 20 to 40 years. Consumers are already exerting choices and preferences that have a profound impact on food production and supply, while companies in the food system have great political and societal influence and can shape consumer preferences.

In this talk Brendan O’Connell will summarise key messages from the event and reflect on the outcomes relevant to New Zealand.

As a member of the senior executive at Tru-Test Group, Brendan is responsible for strategic, technical and market analysis of major new business opportunities. 

Brendan is Vice Chairman of the Precision Agriculture Association established in 2013. PAANZ encourages understanding and development of precision agriculture farm practices appropriate to NZ farming systems.

His experience includes leading R&D teams as well as developing technology and business strategies.  Prior to joining global agritech business Tru-Test Group, Brendan worked on product innovation in various industries including: bio-medical (BioMedical Research), telecommunications (Nokia) and consumer electronics (Navman). He has been working in the Agritech sector for 10 years.

RSVP
Please reply YES in the subject line by email.

Date and time
4.30-6.30 pm drinks and canapés (for 5.00 pm presentation), Friday 12th August.

Venue
Reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds St (see map).

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.



An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 22nd July, 2016
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences.
Guest Speaker:  This month we welcome Doug Wilson speaking on Adherium: a 14 year story of resilience and rapid change

The story of Adherium is a 14 year story of resilience and rapid change. Digital medicine requires the development of software, firmware, telecommunications, the marriage of sensors and astute positioning of monitoring devices, and a clear view of how this might these assist the target patients. The company began as Nexus6 in 2001 created by its current CEO, Garth Sutherland who, as an asthma sufferer, knew that patients with chronic respiratory disease exacerbated their condition by suboptimal use of their medication. The Smartinhaler was born: a digital device that monitors inhaler usage and encourages patients to maintain medication at the right levels for their condition. Clinical trials have shown outstanding improvements. Tens of thousands of patients on over 30 countries are currently being monitored daily. Data is king.

A restructure in 2015 saw the company become Adherium, partner AstraZeneca, the world leader in inhalers, list on the ASX, obtain regulatory approvals in new markets and extend their partnering to additional pharmaceutical companies. In his talk Doug Wilson will discuss the journey from a New Zealand start-up to a respected global corporation.

Garth Sutherland and his Adherium team have shown that serious, innovative creativity is alive and well in NZ, but commercial success demands this has to be coupled with huge persistence and imagination, a fierce approach to solving problems, and a passion for beating your international competition. Matching the local guys might give a nice buzz, but the target is the world.

Doug Wilson has had a remarkable international career becoming head of the Boehringer Ingelheim worldwide medical research group overseeing all research programmes and working on upward of 100 drugs and then as their head of Medicine and Regulatory Affairs.

Prior to that he worked for the company for ten years in the USA where he oversaw a team of 400; including a number of medical staff and was responsible for over 50 parallel drug developments.

Today he is Chair of Adherium, Director of ASX-listed biotech Phylogica (a drug discovery company) and is a director of AFT Pharmaceuticals.

RSVP
Please reply YES in the subject line by email

Date and time
4.30-6.30 pm drinks and canapés (for 5.00 pm presentation), 22nd July

Venue
Reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds St (see map).

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.



An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 17th June, 2016
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences.
Guest Speaker:  This month we welcome Margaret Malloch speaking on the topic: From milk testing services to Smart Data for farmers.

During the dairy season MilkTestNZ processes 25,000 samples per day and their analysis for fat and protein determines the dairy company pay-out to their farmers. To handle this efficiently, and the same day reporting back to farmers, the company has a huge dependency on its robotic processing and sophisticated IT infrastructure. But the company is much more and has an important businesses ensuring the integrity of the milk supply and providing additional services to farmers based on the insights that can be derived from regular milk samples from virtually every dairy farm in New Zealand.

In her talk, Margaret Malloch will discuss the transition from testing services to a modern business providing smart data to farmers. For example, reporting aflatoxin levels caused by feed supplements incubating fungi. Antibiotics, nonylphenyl ethoxylates and agricultural chemicals such as DDT are routinely tested. The 1080 threat and the company's involvement will also be covered. MilkTestNZ has pioneered services such as milk urea levels that help farmers improve their feed budgeting and environmental management. There is more to come from the developmental pipeline.

The reinvention of MilkTestNZ has been managed by Margaret Malloch its CEO and previously GM for the last 13 years where she has introduced sophisticated analytical technologies and automation.

She has extensive laboratory experience across a range of disciplines including Medical, Food and Dairy having held positions with Waikato District Health Board, Counties Manukau Health, MAF Quality Management, AgriQuality, NZ Dairy Group and Kiwi Dairies. Her main focus has been in operational roles with an extensive background in microbiology, biochemistry and immunology.

RSVP
Please reply YES in the subject line by email

Date and time
4.30-6.30 pm drinks and canapés (for 5.00 pm presentation), Friday June 17th.

Venue
Reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds St (see map). 

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 13th May, 2016
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences.
Guest Speaker:  This month we welcome Distinguished Professor Bill Denny speaking on the topic: Hypoxia-activated prodrugs for cancer: from concept to clinic with PR-104

Bill Denny will cover the story of PR-104, the hypoxia-activated prodrug for cancer: from concept through refinement to clinical candidate and clinical trial (the latter with the UniServices’ startup company Proacta Inc, a story in itself). What was learned, what went wrong and its current status.

Distinguished Professor Bill Denny is Director of the Auckland Cancer Society Research Centre at the University of Auckland, where he also leads medicinal chemistry research. He has led or been closely involved in the design and development of twelve new drugs brought to clinical trials, in collaboration with different commercial partners, and was a scientific co-founder of the start-up companies Proacta Inc and Pathway Therapeutics. In 2014 he received the American Chemical Society’s Division of Medicinal Chemistry Award for outstanding contributions to medicinal chemistry, the first such award given outside the United States in more than 30 years.

RSVP
Please reply YES in the subject line by email to m.burgess@auckland.ac.nz

Date and time
4.30-6.30 pm drinks and canapés (for 5.00 pm presentation), Friday 13th May

Venue
Reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds St (see map). 

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 18th March, 2016
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences.
Guest Speaker:  BioPacific Partners, speaking on the topic: Working with Global Biotech Companies that Outsource Innovation.

BioPacific Partners has engaged with over 50 multinational companies in the health, food and agricultural sectors since its inception. In this presentation BioPacific will share its insights into how the multinationals operate and what ‘ticks the boxes’ of their teams that are charged with sourcing and evaluating external innovation.

And BioPacific Partners is also sponsoring the annual Sabre Champagne celebration that recognizes the latest cohort of MBioEnt’s who have just submitted their theses.

BioPacific Partners was founded in 2014 by Dr Andrew Kelly and Ms Margot Bethell with the aim of increasing investment from multinationals into life-science innovation generated in New Zealand and Australia. This company follows on from BioPacific Ventures, a $100M venture fund led by Andrew since 2005. BioPacific Ventures was the only venture fund in this region to specialise across the life sciences. BioPacific Partners has kept the same specialisation and has also expanded its investment focus to include collaborative research, licencing and joint ventures as well as equity investment.

RSVP
Please reply YES in the subject line by email

Date and time
4.30-6.30 pm drinks and canapés (for 5pm presentation), Friday, 18th March 2016

Venue
Reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds St (see map).

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.